Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 30 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.47 Insider Own43.96% Shs Outstand29.25M Perf Week22.92%
Market Cap108.41M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float16.42M Perf Month33.09%
Income-13.69M PEG- EPS next Q- Inst Own1.35% Short Float / Ratio0.35% / 1.57 Perf Quarter-18.86%
Sales0.00M P/S- EPS this Y- Inst Trans- Short Interest0.06M Perf Half Y-22.43%
Book/sh0.41 P/B9.13 EPS next Y- ROA-122.21% Target Price- Perf Year-
Cash/sh0.51 P/C7.29 EPS next 5Y- ROE-357.82% 52W Range2.46 - 48.99 Perf YTD-68.51%
Dividend- P/FCF- EPS past 5Y-83.49% ROI-111.59% 52W High-92.45% Beta-
Dividend %- Quick Ratio2.68 Sales past 5Y-20.00% Gross Margin- 52W Low50.41% ATR0.31
Employees27 Current Ratio2.71 Sales Q/Q- Oper. Margin0.00% RSI (14)65.43 Volatility13.81% 8.82%
OptionableNo Debt/Eq0.04 EPS Q/Q77.92% Profit Margin- Rel Volume2.36 Prev Close3.73
ShortableYes LT Debt/Eq0.03 Earnings- Payout- Avg Volume36.84K Price3.70
Recom- SMA2025.76% SMA5030.26% SMA200-7.42% Volume87,049 Change-0.80%
Monogram Orthopaedics, Inc. operates as a medical technology company. It intends to produce and market robotic surgical equipment and related software, orthopaedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. The company was founded by Douglas Unis in 2015 and is headquartered in Austin, TX.